Vikram Purohit's Stock Ratings

Morgan Stanley Analyst

Vikram Purohit is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/14/2024

Overall Average Return

-23.8%

Smart Score

36.6%

Overall Average Return Percentile

10th

Number of Ratings

134
No data available to display
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert

Recent Analyst Stock Rating News

Peeling Back The Layers: Exploring Axsome Therapeutics Through Analyst Insights
In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.
Demystifying Sage Therapeutics: Insights From 5 Analyst Reviews
Peeling Back The Layers: Exploring Sage Therapeutics Through Analyst Insights
Breaking Down Halozyme Therapeutics: 7 Analysts Share Their Views
Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher
Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.
Expert Outlook: Halozyme Therapeutics Through The Eyes Of 4 Analysts
Expert Outlook: Halozyme Therapeutics Through The Eyes Of 4 Analysts
Why Recursion Pharmaceuticals (RXRX) Stock Is Falling Thursday
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares are trading lower on Thursday as traders appear to be taking profits. The stock rallied on Wednesday after the company announced a $50 m
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free